Grantham, Mayo, Van Otterloo & Co (GMO)’s Amphenol APH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.34M Buy
26,502
+1,520
+6% +$110K 0.01% 418
2026
Q1
$1.58M Buy
24,982
+4,388
+21% +$309K ﹤0.01% 461
2025
Q4
$1.39M Buy
20,594
+72
+0.4% +$4.82K ﹤0.01% 455
2025
Q3
$1.27M Buy
+20,522
New +$1.13M ﹤0.01% 439
2020
Q2
Sell
-168,120
Closed -$1.53M 747
2020
Q1
$1.53M Buy
+168,120
New +$2M 0.01% 435
2019
Q4
Sell
-5,702,200
Closed -$68.8M 685
2019
Q3
$68.8M Buy
5,702,200
+158,400
+3% +$1.83M 0.48% 44
2019
Q2
$66.5M Sell
5,543,800
-358,400
-6% -$4.31M 0.47% 51
2019
Q1
$69.7M Sell
5,902,200
-496,000
-8% -$5.55M 0.5% 43
2018
Q4
$64.8M Buy
6,398,200
+231,200
+4% +$2.48M 0.52% 47
2018
Q3
$72.5M Sell
6,167,000
-2,872
-0% -$33.4K 0.49% 47
2018
Q2
$67.2M Sell
6,169,872
-479,312
-7% -$5.22M 0.48% 50
2018
Q1
$71.6M Buy
6,649,184
+617,600
+10% +$6.95M 0.44% 55
2017
Q4
$66.2M Sell
6,031,584
-36,800
-0.6% -$405K 0.39% 56
2017
Q3
$64.2M Sell
6,068,384
-315,784
-5% -$3.1M 0.38% 61
2017
Q2
$58.9M Buy
6,384,168
+156,000
+3% +$1.42M 0.33% 67
2017
Q1
$55.4M Sell
6,228,168
-64,928
-1% -$562K 0.31% 76
2016
Q4
$52.9M Buy
6,293,096
+478,160
+8% +$3.98M 0.28% 93
2016
Q3
$47.2M Buy
5,814,936
+219,720
+4% +$1.67M 0.22% 111
2016
Q2
$40.1M Buy
5,595,216
+854,872
+18% +$6.15M 0.16% 123
2016
Q1
$34.3M Sell
4,740,344
-1,178,176
-20% -$7.65M 0.13% 149
2015
Q4
$38.6M Sell
5,918,520
-1,083,080
-15% -$7.24M 0.14% 124
2015
Q3
$44.6M Sell
7,001,600
-1,522,960
-18% -$10.2M 0.15% 111
2015
Q2
$61.8M Sell
8,524,560
-1,278,400
-13% -$9.18M 0.2% 90
2015
Q1
$72.2M Sell
9,802,960
-372,712
-4% -$2.61M 0.22% 79
2014
Q4
$68.4M Buy
10,175,672
+147,192
+1% +$942K 0.18% 85
2014
Q3
$62.6M Buy
10,028,480
+1,488,576
+17% +$9.33M 0.17% 93
2014
Q2
$51.4M Buy
8,539,904
+6,732,816
+373% +$40.1M 0.14% 91
2014
Q1
$10.4M Buy
+1,807,088
New +$10.1M 0.03% 204

Other funds holding APH

Grantham, Mayo, Van Otterloo & Co (GMO)'s APH Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Amphenol (APH) stake by 6.1% in Q2 2026, buying an estimated $110K and bringing the position to 26,502 shares worth $2.34M. The position accounts for 0.01% of the portfolio, ranked #418.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in APH in Q1 2014 and has held it in 28 quarters since. The position peaked at $72.5M in Q3 2018. 2,328 funds tracked by Wall St. Rank hold APH as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 26,502 shares of Amphenol worth $2.34M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 1,520 Amphenol shares in Q2 2026, an estimated $110K.
  • Amphenol made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #418 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Amphenol in Q1 2014 and has held it in 28 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Amphenol position peaked at $72.5M in Q3 2018.
  • 2,328 funds tracked by Wall St. Rank held Amphenol as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.